BioFocus Extends its Collaboration with The Michael J. Fox Foundation
News Apr 18, 2013
BioFocus has announced that it has extended its collaboration agreement with The Michael J. Fox Foundation for Parkinson’s Research, a not-for-profit organization focused on developing therapies for Parkinson’s disease.
Based on the success of the project to date, BioFocus will continue the optimization of agents for disease specific biomarkers.
“We have worked with The Michael J. Fox Foundation since 2011 to identify and optimize a-synuclein imaging agents, and are delighted that the progress supports an extension to this collaboration,” said Dr Chris Newton, Managing Director, BioFocus.
Dr Newton continued, “The program will utilize BioFocus' leading biology and chemistry platforms, and will capitalize on the company’s highly experienced teams and state-of-the-art technologies.”
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Synaptic Proteins May Be Starting Point for Dementia TreatmentNews
A new study has identified key proteins, located at the brain's synaptic connections, which may be viable targets for dementia treatment.READ MORE
Comments | 0 ADD COMMENT
Precision Medicine & Biomarkers Leaders Summit: USA
May 07 - May 08, 2018